Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersAdjuvant therapy for pancreas cancer in an era of value based cancer careGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes.Hereditary breast cancer: ever more pieces to the polygenic puzzle.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersExpression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers.Two decades after BRCA: setting paradigms in personalized cancer care and preventionIdentification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.Characterization of the rs2802292 SNP identifies FOXO3A as a modifier locus predicting cancer risk in patients with PJS and PHTS hamartomatous polyposis syndromesGenome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer.Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriersIdentification of six new susceptibility loci for invasive epithelial ovarian cancer.Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersMAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities StudyCell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY TechnologyGENESIS: a French national resource to study the missing heritability of breast cancer.Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersAssociation of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.Interaction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women.Genomic pathways modulated by Twist in breast cancer.Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patientsShift happens: family background influences clinical variability in genetic neurodevelopmental disordersMultiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Discriminatory power of common genetic variants in personalized breast cancer diagnosis.BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersLessons from postgenome-wide association studies: functional analysis of cancer predisposition lociGenomic Biomarkers for Breast Cancer Risk.A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk.RANKL/RANK control Brca1 mutation-driven mammary tumors.Genomic Disparities in Breast Cancer Among Latinas.
P2860
Q21144874-B76D4A28-02A9-42FE-AA12-DDEB5CB6F6F8Q26775916-46E775F9-2ED1-425B-96B0-F23FE84A249EQ27008356-DF5A472F-98DB-4039-B65C-AFE451BFE863Q29416989-7A0E3446-0BCD-4C0F-A09E-56464872FDE0Q30252854-200916E3-D1B5-4603-B485-381C02FC3C01Q30374367-1CB6CC5E-4AFD-4C2E-A7EC-34E4EAE66153Q30992909-F6A564B2-6F4B-415C-B621-704F5F8E5C6DQ33356511-C0113064-7DAA-4AF2-B081-F8E3CBCF81C4Q33614244-8491DA04-A524-4B71-AFC7-3524945F8BC1Q33616077-80FEFAA7-6895-4410-826E-55A961FABA5DQ33820594-61339E96-BA5F-4134-8585-016E4221A1B4Q34038964-B99A278A-11FD-414D-AA48-883AE1CD649EQ34203577-0733A9D3-77F9-4167-B888-105CDB37BE6EQ34375940-48D0C65F-22B6-4207-B9BC-C05394B4C9FCQ34767345-5564CF6C-0319-4ED2-BF48-595F21B64BF7Q34963894-CFA48E81-73DD-465C-818F-1C482AC6E1C0Q35242849-FE9B8C0D-5782-4499-8733-76CE99500A06Q35523236-801BBA91-6833-4D7A-959E-3CCB6D399698Q35541663-171FDC19-3F40-48F8-8F58-4ECF85A1F1A2Q35615396-A4C75ADF-1B11-4BBD-B332-6375D17FA4FDQ35618307-858BC6E6-7B6F-4778-946F-55BC2CD482EEQ35670157-A23192BD-B4B8-4F52-A111-9BE4E4FBD37BQ35693892-67446A61-3EC3-44AE-85D7-EEDD901DCA84Q35746094-BB28AD6F-9DF2-42E7-B420-6B3F47413374Q35892005-AB6DC824-C801-4C7A-94AE-80E290084987Q36087170-DB3131B5-80D5-4D28-ACB2-148BE9852115Q36178189-3B7480D4-60B6-4843-ABA5-D2952C1617ADQ36249029-F649BDDB-EDBA-425D-8285-BFC1DDDC77D0Q36249352-D45CC966-5B1A-40BB-93E3-1AC2411F0F51Q36356727-A5781E45-9447-41A9-A7AD-113E32637999Q36562289-BAC2FBF1-3EFB-47FB-8942-7DA1DCE60D4CQ36773882-757991F8-FE0F-46ED-8ED7-482BA014FE2DQ36897003-88381E68-018E-40A9-9735-0ED654B74EF5Q36972302-E2429BF5-3319-4491-B8FC-997C4C39FBF0Q37002955-3272F7BD-08B9-40B8-8D2E-2410BB7729BDQ37241734-B423E0C0-6B9E-49FC-9AEC-548FB2BA4189Q37242239-15749F22-EEB3-4090-B4D2-D7C209F5AFF9Q37332232-1EBE552C-E03C-4178-AFE0-33716D587C99Q37457304-86CE36E2-883D-4811-9FF8-3192B4598FFBQ37509093-CC806B66-C2CE-4673-A91F-AB3C626F24B4
P2860
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@ast
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@en
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@en-gb
type
label
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@ast
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@en
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@en-gb
prefLabel
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@ast
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@en
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@en-gb
P2093
P2860
P50
P1433
P1476
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
@en
P2093
Adalgeir Arason
Andrew Lee
Annemarie H van der Hout
Ans M W van den Ouweland
Carolien M Kets
Christian F Singer
Christian Sutter
Cora M Aalfs
Daniel C Tessier
Daniel Vincent
P2860
P304
P356
10.1371/JOURNAL.PGEN.1003173
P50
P577
2013-03-27T00:00:00Z